Fred Telling
CIK 1382225 · last filed 2026-01-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$474
Companies
3
Total Filings
81
Lifetime Open-Market Net
$146.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGEN | Director | 948 | $0.50 | $474 | $679.7K | 33 | 2026-01-22 |
| CTI BIOPHARMA CORP (CTIC) Delisted | Director | 78,874 | $9.09 | $717.0K | $0 | 8 | 2018-09-20 |
| CTI BIOPHARMA CORP (TRGT) Delisted | Director | 59,641 | — | — | -$533.2K | 29 | 2014-03-07 |
Recent Filings · Page 5 of 9
81 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-03-18 | OGEN | Grant (A) | +40,000 | $0 | EDGAR |
| 2014-11-17 | OGEN | Buy (P) | +27,000 | $25.5K | EDGAR |
| 2014-03-07 | CTI BIOPHARMA CORP (TRGT) Delisted | Sell (S) | −72,095 | -$270.5K | EDGAR |
| 2014-01-31 | CTI BIOPHARMA CORP (TRGT) Delisted | Grant (A) | +146,000 | $0 | EDGAR |
| 2013-12-12 | CTI BIOPHARMA CORP (TRGT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-12-02 | OGEN | Grant (A) | +38,397 | $0 | EDGAR |
| 2013-10-22 | OGEN | Grant (A) | +33,185 | $0 | EDGAR |
| 2013-06-28 | CTI BIOPHARMA CORP (TRGT) Delisted | Grant (A) | +86,957 | $0 | EDGAR |
| 2013-05-31 | CTI BIOPHARMA CORP (TRGT) Delisted | Sell (S) | −64,798 | -$80.1K | EDGAR |
| 2013-03-22 | CTI BIOPHARMA CORP (TRGT) Delisted | Mixed | +81,798 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.